NYSE
6 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.2574 per share on April 21, 2025, according to a Form 4 filing.

NYSE
13 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells Shares of Kellanova (K) Under 10b5-1 Plan
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.4121 per share on April 14, 2025, according to a Form 4 filing.

NYSE
20 days, 14 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.0297 per share on April 7, 2025, according to a Form 4 filing.

NYSE
30 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.4386 per share on March 28, 2025, according to a Form 4 filing.

NYSE
37 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K) Under 10b5-1 Plan
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) common stock at a price of $82.3071 per share on March 21, 2025, according to a Form 4 filing.

NYSE
44 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K) at $82.26
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) common stock at a price of $82.2554 per share on March 14, 2025, reducing its holdings to 47,618,280 shares.

NYSE
46 days, 16 hours ago 
K
Kellanova
8-K: Kellanova Secures Mars Guarantee for Senior Notes Following Merger Consent Solicitations
Kellanova successfully obtains Mars' guarantee for its senior notes through consent solicitations, contingent on the completion of their merger.

NYSE
51 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.5498 per share on March 7, 2025, according to a Form 4 filing.

NYSE
51 days, 16 hours ago 
K
Kellanova
10-K/A: Kellanova Files Amendment to 10-K, Providing Detailed Executive Compensation and Governance Information
Kellanova's amended 10-K filing includes comprehensive details on director and executive compensation, corporate governance practices, and related party transactions for the fiscal year ended December 28, 2024.

NYSE
58 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova common stock at a price of $82.6978 per share on February 28, 2025, according to a Form 4 filing.

NYSE
59 days, 16 hours ago 
K
Kellanova
8-K: Kellanova Announces RSU Grants to Named Executive Officers
Kellanova's Board of Directors approved restricted stock unit (RSU) grants to its named executive officers on February 21, 2025, under the Kellanova 2022 Long-Term Incentive Plan.

NYSE
61 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Nicolas Amaya Reports Acquisition of Restricted Stock Units
Senior Vice President Nicolas Amaya reports the acquisition of restricted stock units and adjustments to common stock holdings.

NYSE
61 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Executive Charisse Ford Hughes Reports Acquisition of Restricted Stock Units
Senior Vice President Charisse Ford Hughes reports the acquisition of 9,320 restricted stock units of Kellanova common stock.

NYSE
61 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Howell Melissa A Reports Acquisition of Restricted Stock Units
Senior Vice President Howell Melissa A reports acquisition of 19,600 restricted stock units in Kellanova.

NYSE
61 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Executive David Lawlor Reports Acquisition of Restricted Stock Units
Senior Vice President David Lawlor reports the acquisition of restricted stock units in Kellanova.

NYSE
61 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Executive Kris Bahner Reports Acquisition of Restricted Stock Units
Kris Bahner, SVP-Chief Global Corporate Affairs at Kellanova, reports the acquisition of 8,720 restricted stock units on February 21, 2025.

NYSE
61 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Shumit Kapoor Reports Acquisition of Restricted Stock Units
Senior Vice President of Kellanova, Shumit Kapoor, reports the acquisition of 18,880 restricted stock units.

NYSE
61 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Chairman and CEO Steven Cahillane Reports Acquisition of Restricted Stock Units
Steven Cahillane, Chairman and CEO of Kellanova, reports the acquisition of 118,560 restricted stock units.

NYSE
61 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Acquires Restricted Stock Units
Senior Vice President Victor Marroquin acquired 8,470 restricted stock units of Kellanova common stock on February 21, 2025, which vest on February 21, 2028.

NYSE
61 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Executive Amit Banati Reports Stock Transactions
Senior Vice President Amit Banati reports acquisition of restricted stock units and disposal of common stock.

NYSE
61 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Lance Rodrigo Reports Acquisition of Restricted Stock Units
Senior Vice President Lance Rodrigo reports acquisition of Kellanova restricted stock units and updates beneficial ownership.

NYSE
61 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Executive Kurt D Forche Reports Acquisition of Restricted Stock Units
Kurt D Forche, VP-Corporate Controller of Kellanova, reports the acquisition of restricted stock units and updates to beneficial ownership of common stock.

NYSE
61 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Chief Legal Officer Reports Acquisition of Restricted Stock Units
Todd W. Haigh, Chief Legal Officer of Kellanova, reports the acquisition of 17,790 restricted stock units and adjustments to common stock holdings.

NYSE
62 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Amit Banati Reports Stock Transactions
Senior Vice President Amit Banati reports acquisition and disposal of Kellanova common stock and derivative securities, including transactions related to stock options and restricted stock units.

NYSE
62 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Executive Kris Bahner Reports Stock Transactions
Kris Bahner, SVP-Chief Global Corporate Affairs at Kellanova, reports the acquisition and disposal of common stock and derivative securities.

NYSE
62 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Executive Nicolas Amaya Reports Stock Transactions
Nicolas Amaya, a Senior Vice President at Kellanova, reported the acquisition and disposal of company stock and derivative securities.

NYSE
62 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Victor Marroquin Reports Stock Transactions
Senior Vice President Victor Marroquin reports transactions involving Kellanova stock, including the exercise of stock options and restricted stock units, as well as the disposition of shares to cover tax obligations.

NYSE
62 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Chief Legal Officer Reports Stock Transactions
Todd W. Haigh, Chief Legal Officer of Kellanova, reports the acquisition and disposal of common stock and derivative securities.

NYSE
62 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Executive Lance Rodrigo Reports Stock Transactions
Senior Vice President Lance Rodrigo reports exercising stock options and restricted stock units, and disposing of shares to cover taxes.

NYSE
62 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Executive David Lawlor Reports Stock Transactions
David Lawlor, a Senior Vice President at Kellanova, reported the acquisition and disposal of company stock and derivative securities.

NYSE
62 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Chairman and CEO Steven Cahillane Reports Stock Transactions
Steven Cahillane, Chairman and CEO of Kellanova, reports the vesting and disposal of restricted stock units.

NYSE
62 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Executive Kurt D Forche Reports Stock Transactions
Kellanova's VP-Corporate Controller, Kurt D Forche, reports the disposition of shares to cover tax obligations upon vesting of restricted stock units.

NYSE
62 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Howell Reports Stock Transactions
Melissa A. Howell, Senior Vice President of Kellanova, reports the acquisition and disposal of company stock and restricted stock units on February 21, 2025.

NYSE
62 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Charisse Ford Hughes Reports Stock Transactions
Charisse Ford Hughes, a Senior Vice President at Kellanova, reported the acquisition and disposal of company stock and restricted stock units on February 21, 2025.

NYSE
62 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Shumit Kapoor Reports Stock Unit Transaction
Senior Vice President Shumit Kapoor of Kellanova reports the disposition of 26,401 common stock units on February 21, 2025.

NYSE
65 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.5005 per share on February 21, 2025, according to a Form 4 filing.

NYSE
65 days, 16 hours ago 
K
Kellanova
10-K: Kellanova's 2024 10-K Filing: Merger Pending, Snacks Lead Growth Amidst Macroeconomic Headwinds
Kellanova's 2024 results highlight a pending merger with Mars, a focus on snacks-led growth, and navigation of complex macroeconomic conditions following the spin-off of WK Kellogg Co.
Delay expected
 
Worse than expected
 

NYSE
66 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Executive Victor Marroquin Reports Stock Transactions
Senior Vice President Victor Marroquin reports the disposition of Kellanova stock and restricted stock units on February 18, 2025.

NYSE
66 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Executive Rodrigo Lance Reports Stock Transactions
Senior Vice President Rodrigo Lance reports the vesting and disposal of restricted stock units and shares of Kellanova common stock.

NYSE
66 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Executive David Lawlor Reports Stock Transactions
David Lawlor, a Senior Vice President at Kellanova, reported the vesting and subsequent disposal of restricted stock units on February 18, 2025.

NYSE
66 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Shumit Kapoor Reports Stock Transactions
Senior Vice President of Kellanova, Shumit Kapoor, reports the acquisition and disposal of common stock and restricted stock units on February 18, 2025.

NYSE
66 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Executive Charisse Ford Hughes Reports Stock Transactions
Senior Vice President Charisse Ford Hughes of Kellanova reports the acquisition and disposal of common stock and restricted stock units on February 18, 2025.

NYSE
66 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Executive Howell Reports Stock Transactions
Senior Vice President Melissa A. Howell of Kellanova reports the vesting and subsequent sale of restricted stock units.

NYSE
66 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Chief Legal Officer Reports Stock Transactions
Todd W. Haigh, Chief Legal Officer of Kellanova, reports the acquisition and disposal of company stock and restricted stock units on February 18, 2025.

NYSE
66 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova VP-Corporate Controller Kurt D Forche Reports Stock Transactions
Kurt D Forche, VP-Corporate Controller of Kellanova, reports the acquisition and disposal of common stock and restricted stock units on February 18, 2025.

NYSE
66 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Chairman and CEO Steven Cahillane Reports Stock Transactions
Steven Cahillane, Chairman and CEO of Kellanova, reports the acquisition and disposal of company stock and restricted stock units on February 18, 2025.

NYSE
66 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Amit Banati Reports Stock Transactions
Senior Vice President Amit Banati of Kellanova reports the acquisition and disposal of common stock and restricted stock units on February 18, 2025.

NYSE
66 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova SVP-Chief Global Corp Affairs, Kris Bahner, Reports Stock Transactions
Kris Bahner, SVP-Chief Global Corp Affairs at Kellanova, reports the vesting and subsequent sale of restricted stock units.

NYSE
66 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Executive Nicolas Amaya Reports Stock Transactions
Senior Vice President Nicolas Amaya reports the acquisition and disposal of Kellanova common stock and restricted stock units on February 18, 2025.

NYSE
72 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.2528 per share on February 14, 2025, according to a Form 4 filing.

NYSE
72 days, 16 hours ago 
K
Kellanova
Form 4: Kellanova Director Stephanie Burns Reports Changes in Beneficial Ownership
Director Stephanie Burns reports a transaction involving phantom stock units and indirect ownership of common stock in Kellanova.

NYSE
72 days, 16 hours ago 
K
Kellanova
Form 4: Kellanova Director Gund Reports Changes in Beneficial Ownership
Director G. Zachary Gund reports changes in beneficial ownership of Kellanova shares, including acquisitions of phantom stock units and holdings in various trusts and partnerships.

NYSE
76 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.2309 per share on February 10, 2025, according to a Form 4 filing.

NYSE
81 days, 0 hours ago 
K
Kellanova
8-K: Kellanova Reports Strong Q4 and Full Year 2024 Results Amidst Pending Mars Acquisition
Kellanova announced strong fourth quarter and full year 2024 results, marked by organic growth and improved profitability, while preparing for its acquisition by Mars, Incorporated.
Better than expected
 

NYSE
89 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $81.9092 per share on January 28, 2025, according to a Form 4 filing.

NYSE
96 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $81.6862 per share on January 21, 2025, according to a Form 4 filing.

NYSE
103 days, 14 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova
The Kellogg W K Foundation Trust sold 114,583 shares of Kellanova stock at a price of $81.4214 per share on January 14, 2025.

NYSE
110 days, 14 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova Stock
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova stock at a price of $81.2809 per share on January 7, 2025.

NYSE
118 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.8464 per share on December 30, 2024, according to a Form 4 filing with the SEC.

NYSE
125 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells Shares of Kellanova (K) Under 10b5-1 Plan
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.6424 per share on December 23, 2024, according to a Form 4 filing.

NYSE
132 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova Stock
The Kellogg W K Foundation Trust sold 114,583 shares of Kellanova stock at a price of $80.6892 per share on December 16, 2024.

NYSE
136 days, 15 hours ago 
K
Kellanova
8-K: Kellanova Secures $750 Million Credit Facility, Replacing Existing Agreement
Kellanova has entered into a new $750 million unsecured 364-Day Credit Agreement, replacing its previous facility and providing funds for general corporate purposes.

NYSE
139 days, 14 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova Stock
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova stock at a price of $80.6986 per share on December 9, 2024.

NYSE
149 days, 18 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova Stock
The Kellogg W K Foundation Trust sold 114,583 shares of Kellanova stock at a price of $81.2129 per share on November 29, 2024.

NYSE
157 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova Stock
The Kellogg W K Foundation Trust sold 114,583 shares of Kellanova stock at a price of $80.9916 per share on November 21, 2024.

NYSE
160 days, 16 hours ago 
K
Kellanova
Form 4: Kellanova Executive Kris Bahner Reports Stock Transactions
Kellanova's SVP-Chief Global Corporate Affairs, Kris Bahner, reported the acquisition and disposal of company stock and restricted stock units on November 16, 2024.

NYSE
164 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova Stock
The Kellogg W K Foundation Trust sold 114,583 shares of Kellanova stock at a price of $81.0448 per share.

NYSE
164 days, 16 hours ago 
K
Kellanova
Form 4: Kellanova Director Stephanie Burns Reports Acquisition of Phantom Stock Units
Director Stephanie Burns of Kellanova reported the acquisition of 162.82 phantom stock units, as well as holding 31,293.436 common shares in trust.

NYSE
164 days, 16 hours ago 
K
Kellanova
Form 4: Kellanova Director G. Zachary Gund Reports Acquisition of Phantom Stock Units
Director G. Zachary Gund reported the acquisition of 325.64 phantom stock units in Kellanova, along with holdings of common stock through various trusts and partnerships.

NYSE
171 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.8862 per share on November 7, 2024, according to a Form 4 filing with the SEC.

NYSE
175 days, 2 hours ago 
K
Kellanova
8-K: Kellanova Shareowners Approve Merger with Acquiror 10VB8, LLC
Kellanova shareholders have approved the merger agreement with Acquiror 10VB8, LLC, paving the way for the company to become a wholly-owned subsidiary.

NYSE
179 days, 1 hours ago 
K
Kellanova
10-Q: Kellanova Reports Q3 2024 Results Amidst Proposed Merger
Kellanova's Q3 2024 results show a slight decrease in net sales but an increase in operating profit, while the company navigates a proposed merger with Mars, Incorporated.
Better than expected
 
Delay expected
 

NYSE
179 days, 1 hours ago 
K
Kellanova
DEFA14A: Kellanova Reports Strong Q3 Results Amidst Pending Acquisition by Mars
Kellanova announced strong third-quarter results, driven by organic growth and improved profitability, while awaiting shareholder approval for its acquisition by Mars, Incorporated.
Better than expected
 

NYSE
179 days, 1 hours ago 
K
Kellanova
8-K: Kellanova Reports Strong Q3 Results Amidst Pending Mars Acquisition
Kellanova announced strong third-quarter results for 2024, marked by double-digit operating profit and earnings per share growth, while a merger with Mars, Incorporated is pending.
Better than expected
 

NYSE
181 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.7609 per share on October 28, 2024, according to a Form 4 filing.

NYSE
188 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.9598 per share on October 21, 2024, according to a Form 4 filing.

NYSE
188 days, 17 hours ago 
K
Kellanova
DEFA14A: Kellanova Addresses Lawsuits and Demand Letters Related to Mars Merger with Supplemental Disclosures
Kellanova is supplementing its definitive proxy statement with additional disclosures to address claims made in lawsuits and demand letters regarding the proposed merger with Mars, Incorporated.

NYSE
188 days, 17 hours ago 
K
Kellanova
8-K: Kellanova Amends Proxy Statement Following Merger Lawsuits and Shareholder Demands
Kellanova has supplemented its definitive proxy statement related to its merger with Acquiror 10VB8, LLC, following lawsuits and demand letters from shareholders alleging misrepresentations and omissions.
Worse than expected
 

NYSE
194 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.6254 per share on October 14, 2024, according to a Form 4 filing.

NYSE
198 days, 16 hours ago 
K
Kellanova
DEFA14A: Kellanova Urges Stockholders to Vote on Proposed Merger
Kellanova is soliciting proxies for a special meeting of stockholders to approve a proposed merger, with voting directions due by October 29, 2024.

K 
Kellanova 
NYSE

8-K: Kellanova Reports Strong Q3 Results Amidst Pending Mars Acquisition

Sentiment:
 Quarterly Report
 31 October 2024 8:08 AM

Kellanova announced strong third-quarter results for 2024, marked by double-digit operating profit and earnings per share growth, while a merger with Mars, Incorporated is pending.

Better than expected
  The company's organic net sales growth of 6.1% exceeded expectations.  The company's double-digit operating profit growth was better than expected.  The company's earnings per share growth was better than expected. 

Summary
  • Kellanova's third-quarter 2024 results show a mixed picture with reported net sales decreasing by 0.7% year-over-year to $3,233 million, but organic net sales increasing by 6.1% to $3,452 million.
  • The company's reported operating profit increased by 10.3% to $456 million, while adjusted operating profit rose by 16.1% to $441 million, and currency-neutral adjusted operating profit increased by 19.4% to $453 million.
  • Reported diluted earnings per share saw a significant increase of 84.2% to $1.05, while adjusted diluted earnings per share increased by 18.2% to $0.91, and currency-neutral adjusted diluted earnings per share increased by 19.5% to $0.92.
  • Year-to-date, reported net sales decreased by 3.2% to $9,625 million, but organic net sales increased by 5.2% to $10,411 million.
  • Year-to-date reported operating profit increased by 13.9% to $1,342 million, while adjusted operating profit increased by 18.3% to $1,451 million, and currency-neutral adjusted operating profit increased by 21.7% to $1,492 million.
  • Year-to-date reported diluted earnings per share increased by 35.4% to $2.83, while adjusted diluted earnings per share increased by 19.6% to $2.93, and currency-neutral adjusted diluted earnings per share increased by 22.0% to $2.99.
  • The company's free cash flow year-to-date was $853 million, a decrease of $41 million from the previous year.
  • Kellanova is in the process of being acquired by Mars, Incorporated for $83.50 per share in cash, with a shareholder vote scheduled for November 1, 2024, and the transaction expected to close in the first half of 2025.
Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results, particularly in organic growth and profitability. The pending acquisition by Mars is a significant positive development, although it introduces some uncertainty. The sentiment is overall optimistic, but tempered by the lack of forward guidance and some negative impacts from currency translation.

Highlights
  • Kellanova's organic net sales grew by 6.1% in the third quarter, exceeding its long-term target range.
  • The company sustained double-digit operating profit growth, improving profit margins faster than expected.
  • Earnings per share continued their double-digit growth momentum due to higher operating profit.
  • Reported diluted earnings per share increased by 84.2% year-over-year in the third quarter.
  • Currency-neutral adjusted operating profit increased by 19.4% in the third quarter.
  • The company's free cash flow year-to-date was $853 million.
  • A definitive agreement is in place for Mars, Incorporated to acquire Kellanova for $83.50 per share in cash.
Positives
  • Organic net sales growth was strong at 6.1% for the quarter and 5.2% year-to-date, indicating solid underlying business performance.
  • Operating profit showed significant growth, with a 10.3% increase on a reported basis and a 19.4% increase on a currency-neutral adjusted basis for the quarter.
  • Earnings per share saw substantial growth, with an 84.2% increase on a reported basis and a 19.5% increase on a currency-neutral adjusted basis for the quarter.
  • The company is improving profit margins faster than expected.
  • Volume growth and currency-driven price/mix growth in emerging markets drove strong organic net sales growth.
  • Developed markets also generated organic growth on sequentially improving volume performance.
  • Productivity and moderating cost inflation aided in improving profit margins.
Negatives
  • Reported net sales decreased by 0.7% in the third quarter and 3.2% year-to-date, primarily due to adverse currency translation.
  • Free cash flow decreased by $41 million year-to-date compared to the previous year.
  • Latin America's reported operating profit decreased by 26% in the third quarter due to adverse currency translation and higher costs.
  • Asia Pacific, Middle East and Africa's reported net sales decreased by 10% due to adverse currency translation.
  • The company incurred up-front charges related to network optimization projects and the proposed Mars merger.
Risks
  • Adverse currency translation significantly impacted reported net sales and operating profit, particularly in Latin America and AMEA.
  • The pending merger with Mars, Incorporated introduces uncertainty regarding the company's future operations and strategy.
  • The merger is subject to shareholder and regulatory approvals, which may not be obtained or may be delayed.
  • The company is not providing forward-looking guidance due to the pending merger.
  • There are risks associated with the proposed transaction disrupting the company's current plans and operations.
  • The company faces potential litigation relating to, or other unexpected costs resulting from, the merger.
  • There is a risk that the proposed transaction could have an adverse effect on the ability to retain and hire key personnel, to retain customers and to maintain relationships with business partners, suppliers and customers.
Future Outlook

Due to the pending merger with Mars, Incorporated, Kellanova will not be providing forward-looking guidance.

Management Comments
  • Our strong third-quarter results reflect once again our strategy and more growth-oriented and profitable portfolio as Kellanova, commented Steve Cahillane, Kellanovas Chairman, President, and Chief Executive Officer.
  • This performance is also a testament to the talent and engagement of a Kellanova organization that is executing at a high level as we prepare for our exciting next chapter as part of a global snacking powerhouse with Mars.
Industry Context

The results reflect a trend of companies focusing on core brands and profitability, with Kellanova's shift towards a more growth-oriented portfolio aligning with this trend. The pending acquisition by Mars, a major player in the snacking industry, indicates a consolidation trend in the sector.

Comparison to Industry Standards
  • Kellanova's organic net sales growth of 6.1% in Q3 is strong compared to some of its peers in the packaged food industry, which have been facing challenges with volume declines and inflationary pressures.
  • Companies like Mondelez International (MDLZ) and Nestle (NESN) have also been focusing on price increases and portfolio optimization to drive growth, but Kellanova's growth in emerging markets appears to be a key differentiator.
  • The double-digit operating profit growth is also notable, as many companies in the sector are struggling to maintain margins due to rising input costs.
  • The pending acquisition by Mars is a significant event, as it will create a major player in the global snacking market, potentially impacting the competitive landscape for other companies like PepsiCo (PEP) and General Mills (GIS).
Stakeholder Impact
  • Shareholders are expected to benefit from the proposed acquisition by Mars, which offers a cash price of $83.50 per share.
  • Employees may experience changes due to the merger, but the management has expressed confidence in the talent and engagement of the organization.
  • Customers and suppliers may see changes in the company's operations and strategy as a result of the merger.
  • Creditors may be impacted by the change in ownership and capital structure.
Next Steps
  • Kellanova shareholders will vote on the proposed merger with Mars, Incorporated on November 1, 2024.
  • The transaction is expected to close in the first half of 2025, subject to shareholder and regulatory approvals.
  • The company will continue to execute its strategy and prepare for the integration with Mars.
Key Dates
  • August 14, 2024: Mars, Incorporated and Kellanova entered into a definitive agreement for Mars to acquire Kellanova.
  • September 26, 2024: Stockholders were mailed the Definitive Proxy Statement regarding the merger.
  • September 28, 2024: End of the third quarter for which financial results are reported.
  • October 2, 2023: The company successfully completed the separation transaction.
  • October 31, 2024: Date of the press release announcing Q3 2024 financial results.
  • November 1, 2024: Shareholder vote on the proposed acquisition by Mars, Incorporated is scheduled.
Keywords
Kellanova, Mars Incorporated, Merger, Acquisition, Snacking, Cereal, Organic Net Sales, Operating Profit, Earnings Per Share, Currency Translation, Financial Results, Q3 2024

K 
Kellanova 
NYSE
Sector: TBD
 
Filings with Classifications
Delay expected
21 February 2025 4:16 PM

Annual Results
  • The exact timing of the completion of the Merger, if at all, cannot be predicted with any certainty.
Worse than expected
21 February 2025 4:16 PM

Annual Results
  • Net sales decreased 2.8% year-over-year, indicating a decline in overall revenue.
Better than expected
6 February 2025 8:02 AM

Earnings Release
  • The company's organic growth exceeded expectations.
  • Profit margins improved faster than anticipated.
  • Earnings per share showed double-digit growth.
Delay expected
31 October 2024 8:10 AM

Quarterly Report
  • The merger with Mars is expected to close in the first half of 2025, but the exact timing cannot be predicted with certainty, indicating a potential delay.
Better than expected
31 October 2024 8:10 AM

Quarterly Report
  • The company's operating profit increased by 10% year-over-year, indicating better than expected profitability.
  • Diluted EPS increased by 84% to $1.05, showing better than expected earnings.
  • Currency-neutral adjusted operating profit increased by 19%, demonstrating better than expected underlying performance.
Better than expected
31 October 2024 8:09 AM

Financial News Release
  • Kellanova's Q3 results exceeded expectations with double-digit operating profit growth and strong earnings per share growth.
  • Organic net sales growth of 6.1% surpassed the company's long-term target range.
Better than expected
31 October 2024 8:08 AM

Quarterly Report
  • The company's organic net sales growth of 6.1% exceeded expectations.
  • The company's double-digit operating profit growth was better than expected.
  • The company's earnings per share growth was better than expected.
Worse than expected
21 October 2024 4:14 PM

Merger Update
  • The document indicates that the company is facing lawsuits and demand letters, which suggests that the initial proxy statement was not well-received by some shareholders.
  • The need for supplemental disclosures implies that the initial disclosures were inadequate or misleading, which is a negative development.
Better than expected
14 August 2024 5:11 PM

Merger Announcement
  • The acquisition price of $83.50 per share represents a significant premium over the recent trading price of Kellanova stock, indicating a better-than-expected outcome for shareholders.
Capital raise
14 August 2024 7:32 AM

Merger Announcement
  • Mars intends to fully finance the acquisition through a combination of cash-on-hand and new debt, for which commitments have been secured.
Better than expected
14 August 2024 7:25 AM

Merger Announcement
  • The acquisition price represents a significant premium over Kellanova's recent trading price, indicating a better than expected outcome for shareholders.
Better than expected
1 August 2024 4:15 PM

Quarterly Report
  • The company's operating profit increased by 18% year-over-year, indicating better than expected profitability.
  • Currency-neutral adjusted operating profit increased by 16%, showing better than expected operational performance.
  • Diluted EPS increased by 17.6% to $1.00, and currency-neutral adjusted diluted EPS increased by 14.4% to $1.03, both better than expected.
Better than expected
1 August 2024 8:03 AM

Quarterly Report
  • Kellanova's results exceeded expectations due to strong organic growth, improved profitability, and increased full-year guidance.
Capital raise
16 May 2024 4:31 PM

Debt Offering Announcement
  • Kellanova raised $300 million through the issuance of 5.750% Senior Notes due 2054.
  • Kellanova also raised 300 million through the issuance of 3.750% Senior Notes due 2034.
Capital raise
9 May 2024 4:59 PM

Debt Offering Announcement
  • Kellanova raised $600 million through the issuance of senior notes.
  • The offering was split between $300 million in USD denominated notes and 300 million in EUR denominated notes.
Better than expected
2 May 2024 4:13 PM

Quarterly Report
  • The company's currency-neutral adjusted operating profit increased by 30%, indicating better than expected operational performance.
  • Currency-neutral adjusted diluted EPS grew by 33%, reflecting better than expected earnings growth.
Better than expected
2 May 2024 8:02 AM

Quarterly Report
  • The company's adjusted operating profit and earnings per share growth exceeded expectations, driven by improved profit margins and effective cost management.
  • The company's free cash flow generation was significantly better than the prior year, indicating improved financial health.
  • The company's reaffirmation of full-year guidance, despite adverse currency movements, suggests confidence in its underlying performance.
Delay expected
20 February 2024 4:20 PM

Annual Results
  • The document mentions that supply pressures are generally decreasing, though weather and geopolitical issues are resulting in other disruptions and logistical delays into 2024.
Better than expected
20 February 2024 4:20 PM

Annual Results
  • The company's organic net sales growth of 8.3% exceeded expectations.
  • The company's operating profit increased by 24.3%, indicating better than expected profitability.
  • The company's currency-neutral adjusted diluted EPS of $3.18 was better than expected.
Better than expected
8 February 2024 8:06 AM

Quarterly Report
  • The company's fourth-quarter results exceeded previous guidance for net sales, operating profit, and earnings per share.

Disclaimer: This summary was generated by artificial intelligence and its accuracy is not guaranteed. The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.